Abstract
Clopidogrel is frequently used in patients undergoing percutaneous coronary interventions for the prevention of recurrent coronary thrombosis. In several monitoring methods a varying degree of platelet inhibition in individuals on Aspirin and Clopidogrel therapy has been reported. Patients which do not show an adequate reduction in platelet function are stratified as “Clopidogrel nonresponders” or “Aspirin non-responders”. However the evidence for an adverse outcome of “non-responders” is limited up to now. We report three cases of Clopidogrel non-responders in patients which experienced a stent thrombosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Calatzis, A., Spannagl, M., Theisen, F., Klauss, V. (2008). Three Cases of In-stent Thrombosis in Patients with Clopidogrel Non-response. In: Scharrer, I., Schramm, W. (eds) 37th Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73535-9_42
Download citation
DOI: https://doi.org/10.1007/978-3-540-73535-9_42
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73534-2
Online ISBN: 978-3-540-73535-9
eBook Packages: MedicineMedicine (R0)